Search Results 201-210 of 17355 for Teratogenic

1. A Study of AP160-Complex in Advanced Solid Tumors - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic, and teratogenic effects on the developing fetus and ...

2. Publications - Roger K. Moreira, M.D. - Mayo Clinic

   Assessment of teratogenic risk associated with the use of fenproporex during gestation. Gen Mol Biol. 1999; 22(3):557-64. PST-20514431. Home; Publications ...

3. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

4. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer - Mayo Clinic

   For this reason and because HER2 antibody conjugated to a topoisomerase 1 inhibitor agents as well as PARP inhibitors are known to be teratogenic; thus ...

5. Creation of PLACENTA/Serum Repository Database: Autoimmunity from Mother To Baby Study - Mayo Clinic

   The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research samples ...

6. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

7. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   Not pregnant and not nursing, because this study involves investigational agents whose genotoxic, mutagenic and teratogenic effects on the developing fetus and ...

8. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   Participation eligibility · Any of the following because this study involves an investigational agent that has known genotoxic, mutagenic, and teratogenic ...

9. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

   Any of the following because this study involves) an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant persons;; Nursing persons ...

10. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown: - Pregnant persons - Nursing persons - Persons of childbearing potential who are ...